Tumour-promoting and Tumour-inhibiting Fractions from Tumours

descriptionPublicationkeyboard_double_arrow_right Article 01 May 1966 United States English Publisher:Springer Science and Business Media LLCJournal:Nature, volume 210, pages 633-634 (issn: 0028-0836, eissn: 1476-4687,

Copyright policy )

Authors: Mamola, N J; Cook, E S;

doi: 10.1038/210633b0

pmid: 5964567

Tumour-promoting and Tumour-inhibiting Fractions from Tumours

- Summary
- Subjects
- Metrics

Abstract

RELATIVELY simple preparatory procedures reported from our laboratories1 have been extended to obtain tumour-promoting fractions (MF1 and MF2) and a tumour-inhibiting fraction from lyophilized ascites sarcoma 37 (carried in BT mice) and dbrB adenocarcinoma (carried in DBA/1 mice).

Country

United States

Related Organizations

Jackson Laboratory
United States
Adelphi University
United States

Keywords

Transplantation:, DBRB, Antineoplastic Agents, Neoplasms, Experimental, Adenocarcinoma, Strains: BT, Biochemistry, Bioassays, Mice, Types of Tumors:, Metabolism:, Prophylaxis:, Carcinogens, Sarcoma 37, Animals, Transplantable Tumors: SAR-37, Techniques:, Neoplasm:, Serology:, DBA

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average